Anastrozole-Impurities | Pharmaffiliates

anastrozole

Anastrozole was first approved for use in the United States in 1995.It is used in the treatment and prevention of breast cancer in women. Reference standards of Anastrozole API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Anastrozole (IPRS/119/12)-from IPC
    [catalogue_number] => PA IPIPRS 119 12
    [category_ids] => ,151,
    [chemical_name] => 
    [weight] => NA
    [form] => 
    [cas] => NA
    [pslug] => anastrozole-iprs-119-12-paipiprs11912
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Anastrozole (IPRS/119/12)-from IPC


  • Catalogue No.:PA IPIPRS 119 12

  • CAS :

    NA

  • Molecular Formula :

  • Molecular Weight : NA